As of 2026-06-01, the Relative Valuation of Ose Immunotherapeutics SA (OSE.PA) is (18.47) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 4.38 EUR, the upside of Ose Immunotherapeutics SA based on Relative Valuation is -521.6%.
The range of the Relative Valuation is (13.37) - (21.51) EUR.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | 5.1x - 9.2x | 7.4x |
| Forward P/E multiples | 5.7x - 9.5x | 8.4x |
| Fair Price | (13.37) - (21.51) | (18.47) |
| Upside | -405.3% - -591.0% | -521.6% |
| Date | P/E |